FIELD: organic chemistry, biochemistry, pharmacy. SUBSTANCE: invention relates to phosphinic acid amides of the formula (I) where R1 means hydrogen atom, alkyl, phenylalkyl, indolyl, phenylalkoxyalkyl, R2 alkylthioalkyl, alkylaminoalkyl; R3 means alkyl or phenyl; R4 means alkyl, phenyl or substituted phenyl, pyridyl, thienyl or furyl and to their optical isomers, diastereomers, enantiomers, pharmaceutically acceptable salts or biohydrolyzed esters that can be used as inhibitors of matrix metalloprotease in treatment of patients with states with excessively elevated activity of indicated enzymes. EFFECT: valuable medicinal properties of compounds. 10 cl, 2 tbl, 21 ex
Authors
Dates
2001-07-10—Published
1997-08-22—Filed